Rheumatology Department, Virgen de las Nieves University Hospital, Granada, Spain.
PLoS One. 2013 Aug 30;8(8):e72732. doi: 10.1371/journal.pone.0072732. eCollection 2013.
The present study was conducted to explore whether single nucleotide polymorphisms (SNPs) in Th1 and Th17 cell-mediated immune response genes differentially influence the risk of rheumatoid arthritis (RA) in women and men. In phase one, 27 functional/tagging polymorphisms in C-type lectins and MCP-1/CCR2 axis were genotyped in 458 RA patients and 512 controls. Carriers of Dectin-2 rs4264222T allele had an increased risk of RA (OR = 1.47, 95%CI 1.10-1.96) whereas patients harboring the DC-SIGN rs4804803G, MCP-1 rs1024611G, MCP-1 rs13900T and MCP-1 rs4586C alleles had a decreased risk of developing the disease (OR = 0.66, 95%CI 0.49-0.88; OR = 0.66, 95%CI 0.50-0.89; OR = 0.73, 95%CI 0.55-0.97 and OR = 0.68, 95%CI 0.51-0.91). Interestingly, significant gender-specific differences were observed for Dectin-2 rs4264222 and Dectin-2 rs7134303: women carrying the Dectin-2 rs4264222T and Dectin-2 rs7134303G alleles had an increased risk of RA (OR = 1.93, 95%CI 1.34-2.79 and OR = 1.90, 95%CI 1.29-2.80). Also five other SNPs showed significant associations only with one gender: women carrying the MCP-1 rs1024611G, MCP-1 rs13900T and MCP-1 rs4586C alleles had a decreased risk of RA (OR = 0.61, 95%CI 0.43-0.87; OR = 0.67, 95%CI 0.47-0.95 and OR = 0.60, 95%CI 0.42-0.86). In men, carriers of the DC-SIGN rs2287886A allele had an increased risk of RA (OR = 1.70, 95%CI 1.03-2.78), whereas carriers of the DC-SIGN rs4804803G had a decreased risk of developing the disease (OR = 0.53, 95%CI 0.32-0.89). In phase 2, we genotyped these SNPs in 754 RA patients and 519 controls, leading to consistent gender-specific associations for Dectin-2 rs4264222, MCP-1 rs1024611, MCP-1 rs13900 and DC-SIGN rs4804803 polymorphisms in the pooled sample (OR = 1.38, 95%CI 1.08-1.77; OR = 0.74, 95%CI 0.58-0.94; OR = 0.76, 95%CI 0.59-0.97 and OR = 0.56, 95%CI 0.34-0.93). SNP-SNP interaction analysis of significant SNPs also showed a significant two-locus interaction model in women that was not seen in men. This model consisted of Dectin-2 rs4264222 and Dectin-2 rs7134303 SNPs and suggested a synergistic effect between the variants. These findings suggest that Dectin-2, MCP-1 and DC-SIGN polymorphisms may, at least in part, account for gender-associated differences in susceptibility to RA.
本研究旨在探讨 Th1 和 Th17 细胞介导的免疫反应基因中的单核苷酸多态性 (SNP) 是否会影响女性和男性患类风湿关节炎 (RA) 的风险。在第一阶段,对 458 名 RA 患者和 512 名对照者的 C 型凝集素和 MCP-1/CCR2 轴中的 27 个功能/标记 SNP 进行了基因分型。携带 Dectin-2 rs4264222T 等位基因的个体患 RA 的风险增加 (OR=1.47,95%CI 1.10-1.96),而携带 DC-SIGN rs4804803G、MCP-1 rs1024611G、MCP-1 rs13900T 和 MCP-1 rs4586C 等位基因的患者患该病的风险降低 (OR=0.66,95%CI 0.49-0.88;OR=0.66,95%CI 0.50-0.89;OR=0.73,95%CI 0.55-0.97;OR=0.68,95%CI 0.51-0.91)。有趣的是,Dectin-2 rs4264222 和 Dectin-2 rs7134303 存在显著的性别特异性差异:携带 Dectin-2 rs4264222T 和 Dectin-2 rs7134303G 等位基因的女性患 RA 的风险增加 (OR=1.93,95%CI 1.34-2.79;OR=1.90,95%CI 1.29-2.80)。此外,还有 5 个其他 SNP 仅与一个性别存在显著关联:携带 MCP-1 rs1024611G、MCP-1 rs13900T 和 MCP-1 rs4586C 等位基因的女性患 RA 的风险降低 (OR=0.61,95%CI 0.43-0.87;OR=0.67,95%CI 0.47-0.95;OR=0.60,95%CI 0.42-0.86)。在男性中,携带 DC-SIGN rs2287886A 等位基因的个体患 RA 的风险增加 (OR=1.70,95%CI 1.03-2.78),而携带 DC-SIGN rs4804803G 的个体患该病的风险降低 (OR=0.53,95%CI 0.32-0.89)。在第二阶段,我们对 754 名 RA 患者和 519 名对照者进行了这些 SNP 的基因分型,在合并样本中,Dectin-2 rs4264222、MCP-1 rs1024611、MCP-1 rs13900 和 DC-SIGN rs4804803 多态性存在一致的性别特异性关联 (OR=1.38,95%CI 1.08-1.77;OR=0.74,95%CI 0.58-0.94;OR=0.76,95%CI 0.59-0.97;OR=0.56,95%CI 0.34-0.93)。对有意义 SNP 的 SNP-SNP 相互作用分析还显示,在女性中存在一个显著的双基因座相互作用模型,但在男性中未发现该模型。该模型由 Dectin-2 rs4264222 和 Dectin-2 rs7134303 SNP 组成,提示这些变体之间存在协同作用。这些发现表明,Dectin-2、MCP-1 和 DC-SIGN 多态性可能至少部分解释了 RA 易感性的性别相关差异。